OAM
Oxford Asset Management Portfolio holdings
AUM
$276M
1-Year Return
17.43%
This Quarter Return
-0.76%
1 Year Return
+17.43%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$209M
AUM Growth
-$14.2M
(-6.4%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-5.95%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
750
New
318
Increased
76
Reduced
53
Closed
298
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$2.27M |
| 2 |
Oracle
ORCL
|
$2.24M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$2M |
| 4 |
Canadian Pacific Kansas City
CP
|
$1.98M |
| 5 |
BlackRock Health Sciences Trust II
BMEZ
|
$1.98M |
Top Sells
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$3.72M |
| 2 |
Cintas
CTAS
|
$3.13M |
| 3 |
BCOV
Brightcove, Inc.
BCOV
|
$2.87M |
| 4 |
Verizon
VZ
|
$2.3M |
| 5 |
Veeva Systems
VEEV
|
$2.22M |
Sector Composition
| 1 | Healthcare | 15.54% |
| 2 | Financials | 12.73% |
| 3 | Technology | 11.96% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Cullinan Oncology
CGEM
$413M
| $119K | 0.06% |
+15,746
| New | +$119K |
|
|
ITOS
402
DELISTED
iTeos Therapeutics
ITOS
| $119K | 0.06% |
+19,889
| New | +$119K |
|
403
Goldman Sachs BDC
GSBD
$1.31B
| $118K | 0.06% |
10,143
-21,316
| -68% | -$248K |
|
404
Quad
QUAD
$334M
| $117K | 0.06% |
21,465
+2,116
| +11% | +$11.5K |
|
405
1-800-Flowers.com
FLWS
$324M
| $117K | 0.06% |
+19,825
| New | +$117K |
|
406
Domo
DOMO
$603M
| $112K | 0.05% |
+14,394
| New | +$112K |
|
407
DocGo
DCGO
$155M
| $110K | 0.05% |
+41,828
| New | +$110K |
|
408
Cytek Biosciences
CTKB
$511M
| $107K | 0.05% |
+26,640
| New | +$107K |
|
409
NexGen Energy
NXE
$4.46B
| $106K | 0.05% |
23,718
-6,643
| -22% | -$29.8K |
|
410
Garrett Motion
GTX
$2.64B
| $102K | 0.05% |
+12,195
| New | +$102K |
|
411
Arvinas
ARVN
$575M
| $102K | 0.05% |
+14,463
| New | +$102K |
|
412
RPC Inc
RES
$1.04B
| $101K | 0.05% |
+18,327
| New | +$101K |
|
413
Rayonier Advanced Materials
RYAM
$397M
| $96.8K | 0.05% |
+16,829
| New | +$96.8K |
|
414
Terns Pharmaceuticals
TERN
$632M
| $91.2K | 0.04% |
33,027
+17,571
| +114% | +$48.5K |
|
415
Bausch Health
BHC
$2.72B
| $86.7K | 0.04% |
+13,399
| New | +$86.7K |
|
416
Myomo
MYO
$37.7M
| $86.7K | 0.04% |
+18,023
| New | +$86.7K |
|
417
Quanterix
QTRX
$211M
| $85.5K | 0.04% |
+13,127
| New | +$85.5K |
|
418
Oxford Square Capital
OXSQ
$172M
| $85.3K | 0.04% |
32,667
-27,745
| -46% | -$72.4K |
|
419
FreightCar America
RAIL
$160M
| $84.9K | 0.04% |
+15,354
| New | +$84.9K |
|
420
Rocket Pharmaceuticals
RCKT
$354M
| $82.1K | 0.04% |
+12,309
| New | +$82.1K |
|
421
Real Brokerage
REAX
$1.1B
| $79.6K | 0.04% |
19,598
+8,856
| +82% | +$36K |
|
|
SSBK
422
DELISTED
Southern States Bancshares
SSBK
| $78.5K | 0.04% |
+2,196
| New | +$78.5K |
|
423
Xeris Biopharma Holdings
XERS
$1.27B
| $76.3K | 0.04% |
+13,901
| New | +$76.3K |
|
424
Designer Brands
DBI
$231M
| $76.3K | 0.04% |
+20,897
| New | +$76.3K |
|
425
Nkarta
NKTX
$161M
| $76.1K | 0.04% |
+41,353
| New | +$76.1K |
|